ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
127.128,06
0,00%
S&P 500
6.013,13
-1,71%
US Dollar vs BRL
5,71154
-0,36%
Bitcoin
95.869,98
-0,42%
Brent Oil
74,15
0,06%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) Notícias

LQDA

Liquidia (LQDA)

Liquidia Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LQDA
DataHoraFonteTítuloCódigoCompanhia
12/02/202519:34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LQDALiquidia Corporation
23/01/202519:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
08/01/202510:00GlobeNewswire Inc.Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
13/11/202409:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
13/11/202408:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
13/11/202408:30GlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
12/11/202410:00GlobeNewswire Inc.Liquidia to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
06/11/202410:00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:LQDALiquidia Corporation
04/11/202410:00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:LQDALiquidia Corporation
18/10/202416:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LQDALiquidia Corporation
07/10/202411:00GlobeNewswire Inc.United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ PatentNASDAQ:LQDALiquidia Corporation
02/10/202407:00GlobeNewswire Inc.Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)NASDAQ:LQDALiquidia Corporation
30/09/202409:00GlobeNewswire Inc.Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual MeetingNASDAQ:LQDALiquidia Corporation
16/09/202410:41GlobeNewswire Inc.Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 MillionNASDAQ:LQDALiquidia Corporation
11/09/202417:41Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:LQDALiquidia Corporation
11/09/202409:29Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:LQDALiquidia Corporation
11/09/202409:26GlobeNewswire Inc.Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing AgreementNASDAQ:LQDALiquidia Corporation
28/08/202409:00GlobeNewswire Inc.Liquidia to Present at Upcoming Investor ConferencesNASDAQ:LQDALiquidia Corporation
22/08/202407:00GlobeNewswire Inc.Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
19/08/202407:00GlobeNewswire Inc.U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)NASDAQ:LQDALiquidia Corporation
16/08/202407:30GlobeNewswire Inc.Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific SessionsNASDAQ:LQDALiquidia Corporation
07/08/202407:30GlobeNewswire Inc.Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
31/07/202409:00GlobeNewswire Inc.Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:LQDALiquidia Corporation
08/07/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
18/06/202409:42GlobeNewswire Inc.Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)NASDAQ:LQDALiquidia Corporation
03/06/202408:00GlobeNewswire Inc.District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ LaunchNASDAQ:LQDALiquidia Corporation
29/05/202409:00GlobeNewswire Inc.Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
13/05/202418:43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
10/05/202409:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
07/05/202409:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:LQDA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BRKM5
BRASKEM PNA
BOV
HOOT4
HOTEIS OTHON PN
BOV
PRIO3
PETRORIO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios